-
1
-
-
0031660364
-
Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
-
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-6.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1552-1556
-
-
Maini, R.N.1
Breedveld, F.C.2
Kalden, J.R.3
Smolen, J.S.4
Davis, D.5
Macfarlane, J.D.6
-
2
-
-
0033524159
-
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
-
Maini RN, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet 1999;354:1932-9.
-
(1999)
Lancet
, vol.354
, pp. 1932-1939
-
-
Maini, R.N.1
St Clair, E.W.2
Breedveld, F.3
Furst, D.4
Kalden, J.5
Weisman, M.6
-
3
-
-
0034735842
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis
-
Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
-
(2000)
N Engl J Med
, vol.343
, pp. 1594-1602
-
-
Lipsky, P.E.1
Van Der Heijde, D.M.2
St Clair, E.W.3
Furst, D.E.4
Breedveld, F.C.5
Kalden, J.R.6
-
4
-
-
0028143212
-
Repeated therapy with monoclonal antibody to tumour necrosis factor-α (cA2) in patients with rheumatoid arthritis
-
Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, et al. Repeated therapy with monoclonal antibody to tumour necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125-7.
-
(1994)
Lancet
, vol.344
, pp. 1125-1127
-
-
Elliott, M.J.1
Maini, R.N.2
Feldmann, M.3
Long-Fox, A.4
Charles, P.5
Bijl, H.6
-
5
-
-
0037389760
-
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
-
De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, et al. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum 2003;48:1015-23.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1015-1023
-
-
De Rycke, L.1
Kruithof, E.2
Van Damme, N.3
Hoffman, I.E.4
Van Den Bossche, N.5
Van Den Bosch, F.6
-
6
-
-
0027438710
-
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α
-
Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor-α. Arthritis Rheum 1993;36:1681-90.
-
(1993)
Arthritis Rheum
, vol.36
, pp. 1681-1690
-
-
Elliott, M.J.1
Maini, R.N.2
Feldmann, M.3
Long-Fox, A.4
Charles, P.5
Katsikis, P.6
-
7
-
-
0033611472
-
A trial of etanercept, a recombinant tumour necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
-
Weinblatt ME, Kremer JM, Bonkhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, et al. A trial of etanercept, a recombinant tumour necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
-
(1999)
N Engl J Med
, vol.340
, pp. 253-259
-
-
Weinblatt, M.E.1
Kremer, J.M.2
Bonkhurst, A.D.3
Bulpitt, K.J.4
Fleischmann, R.M.5
Fox, R.I.6
-
8
-
-
0033574147
-
Etanercept therapy in rheumatoid arthritis: A randomised, controlled trial
-
Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, et al. Etanercept therapy in rheumatoid arthritis: a randomised, controlled trial. Ann Intern Med 1999;130:478-86.
-
(1999)
Ann Intern Med
, vol.130
, pp. 478-486
-
-
Moreland, L.W.1
Schiff, M.H.2
Baumgartner, S.W.3
Tindall, E.A.4
Fleischmann, R.M.5
Bulpitt, K.J.6
-
9
-
-
0013511183
-
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
-
Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
-
(1997)
N Engl J Med
, vol.337
, pp. 141-147
-
-
Moreland, L.W.1
Baumgartner, S.W.2
Schiff, M.H.3
Tindall, E.A.4
Fleischmann, R.M.5
Weaver, A.L.6
-
10
-
-
0034735827
-
A comparison of etanercept and methotrexafe in patients with early rheumatoid arthritis
-
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexafe in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
-
(2000)
N Engl J Med
, vol.343
, pp. 1586-1593
-
-
Bathon, J.M.1
Martin, R.W.2
Fleischmann, R.M.3
Tesser, J.R.4
Schiff, M.H.5
Keystone, E.C.6
-
11
-
-
0033763979
-
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor-α: Findings in open-label and randomised placebo-controlled trials
-
Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor-α: findings in open-label and randomised placebo-controlled trials. Arthritis Rheum 2000;43:2383-90.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 2383-2390
-
-
Charles, P.J.1
Smeenk, R.J.2
De Jong, J.3
Feldmann, M.4
Maini, R.N.5
-
12
-
-
0000337774
-
Serological effects of repeated doses of an engineered human anti-TNF-α antibody, CDP571, in patients with rheumatoid arthritis
-
Rankin ECC, Choy EHS, Ehrenstein MR, Ravirajan CT, Sopwith M, Vetterlein O, et al. Serological effects of repeated doses of an engineered human anti-TNF-α antibody, CDP571, in patients with rheumatoid arthritis [abstract]. Arthritis Rheum 1995;38(suppl):S279.
-
(1995)
Arthritis Rheum
, vol.38
, Issue.SUPPL.
-
-
Rankin, E.C.C.1
Choy, E.H.S.2
Ehrenstein, M.R.3
Ravirajan, C.T.4
Sopwith, M.5
Vetterlein, O.6
-
13
-
-
0036207308
-
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: Direct and indirect evidence of a passible association with infections
-
Ferraccioli GF, Mecchia F, Di Poi E, Fabris M. Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence of a passible association with infections. Ann Rheum Dis 2002;82:358-61.
-
(2002)
Ann Rheum Dis
, vol.82
, pp. 358-361
-
-
Ferraccioli, G.F.1
Mecchia, F.2
Di Poi, E.3
Fabris, M.4
-
14
-
-
0025075078
-
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population
-
Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med 1990;20:231-6.
-
(1990)
Aust N Z J Med
, vol.20
, pp. 231-236
-
-
Shi, W.1
Krilis, S.A.2
Chong, B.H.3
Gordon, S.4
Chesterman, C.N.5
-
15
-
-
0024381408
-
The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies
-
Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
-
(1989)
J Rheumatol
, vol.16
, pp. 623-625
-
-
Fields, R.A.1
Toubbeh, H.2
Searles, R.P.3
Bankhurst, A.D.4
-
16
-
-
0023425978
-
Anticardiolipin antibodies in rheumatoid arthritis
-
Keane A, Woods R, Dawding V, Roden D, Barry C. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol 1987;26:346-50.
-
(1987)
Br J Rheumatol
, vol.26
, pp. 346-350
-
-
Keane, A.1
Woods, R.2
Dawding, V.3
Roden, D.4
Barry, C.5
-
17
-
-
0028108605
-
Anticardiolipin antibodies in rheumatoid arthritis: Their relation to rheumatoid nodules and cutaneous vascular manifestations
-
Wolf P, Gretler J, Aglas F, Auer-Grumbach P, Rainer F. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Br J Dermatol 1994;131:48-51.
-
(1994)
Br J Dermatol
, vol.131
, pp. 48-51
-
-
Wolf, P.1
Gretler, J.2
Aglas, F.3
Auer-Grumbach, P.4
Rainer, F.5
-
18
-
-
0025763635
-
Anticardiolipin antibodies in patients with venous thrombosis
-
Kapiotis S, Speiser W, Pabinger-Fasching I, Kyrle PA, Lechner K. Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 1991;21:19-24.
-
(1991)
Haemostasis
, vol.21
, pp. 19-24
-
-
Kapiotis, S.1
Speiser, W.2
Pabinger-Fasching, I.3
Kyrle, P.A.4
Lechner, K.5
-
19
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
-
20
-
-
0020188574
-
The dimensions of health outcomes: The Health Assessment Questionnaire, Disability and Pain Scale
-
Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, Disability and Pain Scale. J Rheumatol 1982;9:789-93.
-
(1982)
J Rheumatol
, vol.9
, pp. 789-793
-
-
Fries, J.F.1
Spitz, P.W.2
Young, D.Y.3
-
21
-
-
0027238592
-
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
-
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
-
(1993)
Arthritis Rheum
, vol.36
, pp. 729-740
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Chernoff, M.5
Fried, B.6
-
22
-
-
0027420099
-
Development of a disease activity score based on judgment in clinical practice by rheumatologists
-
van der Heijde DM, van't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
-
(1993)
J Rheumatol
, vol.20
, pp. 579-581
-
-
Van Der Heijde, D.M.1
Van't Hof, M.2
Van Riel, P.L.3
Van De Putte, L.B.4
-
23
-
-
0024578482
-
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody
-
Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43.
-
(1989)
Am J Obstet Gynecol
, vol.160
, pp. 439-443
-
-
Lockshin, M.D.1
Druzin, M.L.2
Qamar, T.3
-
24
-
-
0031418574
-
Pro- and anti-inflammatory cytokines in rheumatoid arthritis
-
Isomäki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997;29:499-507.
-
(1997)
Ann Med
, vol.29
, pp. 499-507
-
-
Isomäki, P.1
Punnonen, J.2
-
25
-
-
0036676817
-
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenetic role of B cells
-
De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. Arthritis Rheum 2002;46:2029-33.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2029-2033
-
-
De Vita, S.1
Zaja, F.2
Sacco, S.3
De Candia, A.4
Fanin, R.5
Ferraccioli, G.6
-
26
-
-
0036674876
-
B cell-ablative therapy far the treatment of autoimmune disease
-
Dhavalkumar DP. B cell-ablative therapy far the treatment of autoimmune disease. Arthritis Rheum 2002;46:1984-5.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1984-1985
-
-
Dhavalkumar, D.P.1
-
27
-
-
0036269445
-
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomised, double-blind, placebo controlled trial
-
St Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A, et al. The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomised, double-blind, placebo controlled trial. Arthritis Rheum 2002;46:1451-9.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1451-1459
-
-
St Clair, E.W.1
Wagner, C.L.2
Fasanmade, A.A.3
Wang, B.4
Schaible, T.5
Kavanaugh, A.6
|